This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Henry A. Nasrallah, MD; Matcheri S. Keshavan, MD; Francine M. Benes David, MD; L. Braff Alan I. Green, MD; Rachel E. Gur John M. Kane, MD; Diana O. Perkins , MD, MPH; Peter J. Weiden, MD; Daniel R. Weinberger, MD; and Christoph U. Correll, MD

Published: March 4, 2009

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In mid-February 2008, a panel of 10 nationally recognized schizophrenia research experts wasassembled in a Schizophrenia Summit to focus on controversies that exist in treating patients withschizophrenia. The current literature related to the diagnosis and etiopathology of schizophrenia wasevaluated regarding the identification of a prodromal phase, brain changes, cognitive impairments,genetic factors, and use of neuroimaging in patients with schizophrenia.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: